Core Viewpoint - He Eye Hospital (301103) is focusing on strengthening its core business in the ophthalmology sector while exploring new business lines to create a second profit model through various strategies [1] Group 1: Business Expansion Strategies - The company is enhancing its main business through a combination of "expanding into lower-tier markets and upgrading high-end services" [1] - Investment in new optical business is being increased, utilizing a chain franchise model to provide eye health services to a broader user base [1] - The company is actively expanding into diabetes and other innovative businesses, aiming for precise diabetes control and eye disease prevention throughout the patient's lifecycle [1] Group 2: Strategic Acquisitions and Digital Transformation - He Eye Hospital is acquiring Japan's Medical Path Co., Ltd. to enter the regenerative medicine sector [1] - The company is leveraging "digital transformation and industry chain extension" to create new growth points [1] - Establishing an industrial fund focused on eye health to invest in next-generation healthcare and synthetic biology, forming an innovative ecosystem of "core business + fund incubation" [1] Group 3: Impact on Current Operations - The aforementioned initiatives have not significantly impacted the company's current main business operations or performance [1] - The company commits to timely announcements in accordance with information disclosure requirements if there are significant developments [1]